31.10.2011 • News

LyondellBasell's Q3 Profit Doubles

LyondellBasell's third-quarter profit nearly doubled, widely beating Wall Street's expectations, on strong chemical and oil refining margins.

The company benefited from higher prices for certain types of crude oil, as well as higher efficiency at its flagship Houston refinery, which had been under repairs.

For the third quarter, LyondellBasell reported net income of $895 million, or $1.51 a share, compared with $467 million, or 84 cents a share, in the year-ago period.

Excluding one-time items, LyondellBasell earned $1.53 per share.

By that measure, analysts expected earnings of $1.22 per share, according to Thomson Reuters I/B/E/S.

Revenue rose 29% to $13.29 billion. Analysts expected $13.33 billion.

Operating income in the company's largest unit, which supplies the basic chemical ethylene, jumped 34% to $599 million.

Operating income of the refining unit increased more than fivefold to $454 million.

The shutdown of the unit's Berre, France, refinery due to a labor dispute had ''minimal impact'' on results, LyondellBasell said.

During the quarter LyondellBasell doubled its dividend and said it would pay a separate special dividend.

The company, which emerged from bankruptcy protection last year, also said it would buy back nearly $2.8 billion in debt, substantially improving its balance sheet.

LyondellBasell is technically based in the Netherlands, but is run out of Houston.

 

 

 

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.